MELANIE DRYDEN: Open Payments
NPI 1063714830 · INVERNESS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$302 in 15 payments from 12 companies in 2025. Trend: 2023 $170 · 2024 $338 · 2025 $302
Food & beverage: $302
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 3 | $53 |
| Sage Therapeutics, LLC | 2 | $45 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $34 |
| Supernus Pharmaceuticals, Inc. | 1 | $28 |
| MILLICENT US INC | 1 | $21 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $20 |
| Organon LLC | 1 | $20 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $18 |
| Sumitomo Pharma America, Inc. | 1 | $16 |
| OptumHealth Care Solutions, LLC | 1 | $16 |
Products named: Veozah, ZURZUVAE, Qelbree, INTRAROSA, Mirena, NEXPLANON, JOURNAVX, MYFEMBREE.
Industry payments across FL — which companies pay providers there.
